# Measuring cerebral glucose metabolism by chemical exchange-sensitive spin-lock (CESL) MRI of 2-deoxy-D-glucose in rodents

**Authors:** Philipp Boehm-Sturm, Patrick Schuenke, Marco Foddis, Susanne Mueller, Stefan P. Koch, Daniel J. Beard, Paul Holloway, Amin Mottahedin, Leif Schröder, Alastair M. Buchan, Philipp Mergenthaler

PMC · DOI: 10.1371/journal.pone.0346046 · PLOS One · 2026-03-27

## TL;DR

This paper introduces a new MRI method using 2-deoxy-D-glucose to measure brain glucose metabolism in rodents, which could help study neurological diseases and treatment responses.

## Contribution

The protocol introduces a novel application of CESL MRI with 2DG for metabolic imaging in rodent brains.

## Key findings

- The CESL MRI protocol successfully characterized metabolic changes in ischemic tissue in a rat stroke model.
- The method is adaptable to other disease models with minimal modifications.
- CESL MRI is sensitive to glucose analogs suitable for both animal and human studies.

## Abstract

Magnetic resonance imaging (MRI) of glucose metabolism shows significant potential for identifying disease biomarkers and monitoring therapeutic responses in neurological conditions. Here, we present a protocol utilizing chemical exchange-sensitive spin-lock (CESL) MRI with the glucose analogue 2-deoxy-D-glucose (2DG) in the rat brain. We employed this method to characterize metabolic changes in ischemic tissue in a rat model of stroke. However, the utility of the technique is not limited to stroke and may be adapted to other disease models with minimal modifications. Previous research has demonstrated that CESL MRI is sensitive to various glucose analogs, including regular D-glucose, which is suitable for human application. Consequently, our protocol provides a foundation for a wide range of future applications in both basic and translational research, with potential utility in animal models and, eventually, human studies.

## Linked entities

- **Chemicals:** 2-deoxy-D-glucose (PubChem CID 108223), D-glucose (PubChem CID 5793)
- **Diseases:** stroke (MONDO:0005098)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Diseases:** brain tumors (MESH:D001932), brain disorders (MESH:D001927), brain ischemia (MESH:D002545), neurodegenerative disease (MESH:D019636), toxicity (MESH:D064420), ischemic stroke (MESH:D002544), MCAO (MESH:D020244), acute stroke (MESH:D020521)
- **Chemicals:** D-glucose (MESH:D005947), water (MESH:D014867), 3-O-methyl-D-glucose (MESH:D019325), FDG (MESH:D019788), 2-Deoxy-2-[18F]fluoroglucose (-), 2-deoxy-D-glucose (MESH:D003847)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028544/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028544/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028544/full.md

---
Source: https://tomesphere.com/paper/PMC13028544